vs
Clarus Corp（CLAR）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Clarus Corp的1.2倍（$75.5M vs $65.4M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -8.4%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $11.6M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -2.9%）
Clarus Corp是一家全球性企业，主营高性能户外休闲、登山、露营及生活方式产品的设计、生产与分销，旗下拥有多个知名消费品牌，为北美、欧洲及亚太地区的户外爱好者、专业运动员和零售合作伙伴提供创新耐用的运动装备。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CLAR vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$65.4M
营收增速更快
PBYI
高出36.1%
-8.4%
自由现金流更多
PBYI
多$2.8M
$11.6M
两年增速更快
PBYI
近两年复合增速
-2.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $65.4M | $75.5M |
| 净利润 | $-31.3M | — |
| 毛利率 | 27.7% | 69.3% |
| 营业利润率 | -59.6% | 22.7% |
| 净利率 | -47.8% | — |
| 营收同比 | -8.4% | 27.7% |
| 净利润同比 | 52.3% | — |
| 每股收益（稀释后） | $-0.81 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLARPBYI
| Q4 25 | $65.4M | $75.5M | ||
| Q3 25 | $69.3M | $54.5M | ||
| Q2 25 | $55.2M | $52.4M | ||
| Q1 25 | $60.4M | $46.0M | ||
| Q4 24 | $71.4M | $59.1M | ||
| Q3 24 | $67.1M | $80.5M | ||
| Q2 24 | $56.5M | $47.1M | ||
| Q1 24 | $69.3M | $43.8M |
净利润CLARPBYI
| Q4 25 | $-31.3M | — | ||
| Q3 25 | $-1.6M | $8.8M | ||
| Q2 25 | $-8.4M | $5.9M | ||
| Q1 25 | $-5.2M | $3.0M | ||
| Q4 24 | $-65.5M | — | ||
| Q3 24 | $-3.2M | $20.3M | ||
| Q2 24 | $-5.5M | $-4.5M | ||
| Q1 24 | $21.9M | $-4.8M |
毛利率CLARPBYI
| Q4 25 | 27.7% | 69.3% | ||
| Q3 25 | 35.1% | 77.7% | ||
| Q2 25 | 35.6% | 76.5% | ||
| Q1 25 | 34.4% | 77.1% | ||
| Q4 24 | 33.4% | 76.4% | ||
| Q3 24 | 35.0% | 63.9% | ||
| Q2 24 | 36.1% | 77.4% | ||
| Q1 24 | 35.9% | 75.5% |
营业利润率CLARPBYI
| Q4 25 | -59.6% | 22.7% | ||
| Q3 25 | -4.4% | 17.6% | ||
| Q2 25 | -19.7% | 12.7% | ||
| Q1 25 | -11.2% | 8.7% | ||
| Q4 24 | -70.2% | 22.6% | ||
| Q3 24 | -8.0% | 27.4% | ||
| Q2 24 | -14.4% | -4.6% | ||
| Q1 24 | -9.8% | -5.3% |
净利率CLARPBYI
| Q4 25 | -47.8% | — | ||
| Q3 25 | -2.3% | 16.2% | ||
| Q2 25 | -15.3% | 11.2% | ||
| Q1 25 | -8.7% | 6.5% | ||
| Q4 24 | -91.8% | — | ||
| Q3 24 | -4.7% | 25.2% | ||
| Q2 24 | -9.7% | -9.6% | ||
| Q1 24 | 31.6% | -11.0% |
每股收益（稀释后）CLARPBYI
| Q4 25 | $-0.81 | $0.26 | ||
| Q3 25 | $-0.04 | $0.17 | ||
| Q2 25 | $-0.22 | $0.12 | ||
| Q1 25 | $-0.14 | $0.06 | ||
| Q4 24 | $-1.72 | $0.40 | ||
| Q3 24 | $-0.08 | $0.41 | ||
| Q2 24 | $-0.14 | $-0.09 | ||
| Q1 24 | $0.57 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.7M | $97.5M |
| 总债务越低越好 | $0 | $22.7M |
| 股东权益账面价值 | $196.4M | $130.3M |
| 总资产 | $249.0M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CLARPBYI
| Q4 25 | $36.7M | $97.5M | ||
| Q3 25 | $29.5M | $94.4M | ||
| Q2 25 | $28.5M | $96.0M | ||
| Q1 25 | $41.3M | $93.2M | ||
| Q4 24 | $45.4M | $101.0M | ||
| Q3 24 | $36.4M | $96.7M | ||
| Q2 24 | $46.2M | $96.8M | ||
| Q1 24 | $47.5M | $107.2M |
总债务CLARPBYI
| Q4 25 | $0 | $22.7M | ||
| Q3 25 | $2.0M | $34.0M | ||
| Q2 25 | $1.9M | $45.3M | ||
| Q1 25 | $1.9M | $56.7M | ||
| Q4 24 | $1.9M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | $37.0K | $102.0M |
股东权益CLARPBYI
| Q4 25 | $196.4M | $130.3M | ||
| Q3 25 | $225.8M | $115.3M | ||
| Q2 25 | $225.1M | $104.7M | ||
| Q1 25 | $229.3M | $97.1M | ||
| Q4 24 | $233.1M | $92.1M | ||
| Q3 24 | $308.5M | $71.1M | ||
| Q2 24 | $307.3M | $48.5M | ||
| Q1 24 | $310.4M | $51.0M |
总资产CLARPBYI
| Q4 25 | $249.0M | $216.3M | ||
| Q3 25 | $283.1M | $202.9M | ||
| Q2 25 | $286.5M | $194.9M | ||
| Q1 25 | $292.8M | $196.2M | ||
| Q4 24 | $294.1M | $213.3M | ||
| Q3 24 | $375.3M | $220.7M | ||
| Q2 24 | $369.4M | $205.0M | ||
| Q1 24 | $377.0M | $214.1M |
负债/权益比CLARPBYI
| Q4 25 | 0.00× | 0.17× | ||
| Q3 25 | 0.01× | 0.30× | ||
| Q2 25 | 0.01× | 0.43× | ||
| Q1 25 | 0.01× | 0.58× | ||
| Q4 24 | 0.01× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | 0.00× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | $14.4M |
| 自由现金流率自由现金流/营收 | 17.7% | 19.1% |
| 资本支出强度资本支出/营收 | 1.4% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CLARPBYI
| Q4 25 | $12.5M | $14.4M | ||
| Q3 25 | $-5.7M | $9.7M | ||
| Q2 25 | $-9.4M | $14.1M | ||
| Q1 25 | $-2.1M | $3.6M | ||
| Q4 24 | $16.6M | $15.6M | ||
| Q3 24 | $-8.3M | $11.0M | ||
| Q2 24 | $834.0K | $1.0M | ||
| Q1 24 | $-16.4M | $11.2M |
自由现金流CLARPBYI
| Q4 25 | $11.6M | $14.4M | ||
| Q3 25 | $-7.0M | $9.7M | ||
| Q2 25 | $-11.3M | $14.1M | ||
| Q1 25 | $-3.3M | $3.6M | ||
| Q4 24 | $14.4M | $15.6M | ||
| Q3 24 | $-9.4M | $11.0M | ||
| Q2 24 | $-744.0K | $1.0M | ||
| Q1 24 | $-18.3M | — |
自由现金流率CLARPBYI
| Q4 25 | 17.7% | 19.1% | ||
| Q3 25 | -10.0% | 17.7% | ||
| Q2 25 | -20.4% | 26.8% | ||
| Q1 25 | -5.4% | 7.7% | ||
| Q4 24 | 20.1% | 26.4% | ||
| Q3 24 | -14.0% | 13.7% | ||
| Q2 24 | -1.3% | 2.1% | ||
| Q1 24 | -26.3% | — |
资本支出强度CLARPBYI
| Q4 25 | 1.4% | 0.0% | ||
| Q3 25 | 1.8% | 0.0% | ||
| Q2 25 | 3.4% | 0.0% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 3.1% | 0.0% | ||
| Q3 24 | 1.6% | 0.0% | ||
| Q2 24 | 2.8% | 0.0% | ||
| Q1 24 | 2.7% | 0.0% |
现金转化率CLARPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.75× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLAR
| Other | $37.1M | 57% |
| Outdoor Segment | $25.3M | 39% |
| Adventure Segment | $3.0M | 5% |
PBYI
暂无分部数据
